Our findings suggest that the transcription of HILPDA, HSD17B13, LPCAT1, PLIN3, and RAB10 may be associated with the progression-free survival of HCC patients (Figure S2A). The gene discussed is HSD17B13; the disease is hepatocellular carcinoma.